Viewing options
Standard display
High contrast
Dark blue on cream
Dark on light blue
Change language
  • a
  • a
  • a
Change font size
Leading the way in patient care......

Ash Surgery

Chilton Place
Telephone: 01304 812227
Fax: 01304 813788

Current Immunisation Programmes

  • Childhood Seasonal Flu Programme
  • Seasonal Flu and Pneumococcal Vaccination Programme
  • Hepatitis B vaccination for At Risk Babies
  • Meningitis C for University Freshers
  • Shingles
  • Pertussis in Pregnancy Programme
  • MMR (measles,mumps,rubella) for any who have not completed full course (2 vaccines).


Childhood Seasonal Flu

In 2012 the Joint Committee of Vaccination and Immunisation agreed the planned roll out of flu vaccine to ALL children aged 2-17. This roll out started in 2013, with the vaccination of children aged 2-3yrs.

In 2016 the programme was extended to include all aged two-, three- and four-years of age (but not five years or older) on 31 August 2015. All children of school years 1 and 2 age were also vaccinated by school nurses.

In 2018-19 there is, once again, an increase in the groups of children planned to be offered flu vaccination (see below for details)

The objective of flu immunisation is to protect those at most risk from flu and to reduce spread in the community.

Most children will be offered a single nasal spray vaccine unless this is contraindicated (eg previous allergy).

Those children who are in a “high risk group” for other reasons (not simply their age group- eg asthma/ chronic heart disease or other), will require a booster if they have not had the vaccine before.

In cases where the nasal spray is contraindicated, then the injection should be used. & Files/DoH_8502_Protecting_your_child_against_flu_DL_leaflet_16c_accessible.pdf

Which Flu Vaccine should Which Children have.. Nasal or Injection---2018

To see the guidelines regarding this question, please press here


Seasonal Flu and Pneumococcal Campaign (Adult Protection)

The aim of the vaccination programme is to protect those who are at highest risk from influenza or pneumococcal (pneumonia) disease.

Patients eligible for Seasonal Influenza 2018-2019 season

  1. people aged 65 years or over (including those becoming age 65 years by 31 March 2018) 
  2. people aged from 6 months to less than 65 years of age with a serious medical condition such as: 
  • chronic (long-term) respiratory disease, such as severe asthma, chronic obstructive pulmonary disease (COPD) or bronchitis 
  • chronic heart disease, such as heart failure 
  • chronic kidney disease at stage three, four or five 
  • chronic liver disease 
  • chronic neurological disease, such as Parkinson’s disease or motor neurone disease, or learning disability 
  • diabetes 
  • splenic dysfunction 
  • a weakened immune system due to disease (such as HIV/AIDS) or treatment (such as cancer treatment)
  • morbidly obese (defined as BMI of 40 and above) 
  1. all pregnant women (including those women who become pregnant during the flu season)
  2. all those aged two and three (but not four years or older) on 31 August 2018 (ie date of birth on or after 1 September 2014 and on or before 31 August 2016) 
  3. all children in reception class and school years 1, 2, 3, and 4 
  4. primary school-aged children in former primary school pilots areas 
  5. people living in long-stay residential care homes or other long-stay care facilities where rapid spread is likely to follow introduction of infection and cause high morbidity and mortality. This does not include, for instance, prisons, young offender institutions, or university halls of residence 
  6. people who are in receipt of a carer’s allowance, or those who are the main carer of an older or disabled person whose welfare may be at risk if the carer falls ill 
  7. consideration should also be given to the vaccination of household contacts of immunocompromised individuals, specifically individuals who expect to share living accommodation on most days over the winter and therefore for whom continuing close contact is unavoidable.

This list is not exhaustive, and there may be some who are recommended to have the vaccine although not specifically fitting into one of these groups.

Patients eligible for Pneumococcal Vaccine

  • Aged >65 on or before 31/3/19
  • Aged 2-64 years and in high risk group as defined in “green book”.


Hepatitis B Vaccination for Newborn Babies at Risk

This programme aims to protect new born babies who are at high risk (having Hepatitis B positive mothers) from the sequelae of Hepatitis B.

All pregnant women are offered screening for Hepatitis B in pregnancy.

All new-born babies born to mothers who have tested positive for Hepatitis B in pregnancy should receive a full course of Hepatitis B vaccination. This involves 4 doses given at birth, 1 month, 2month and then at 12 months of age. At 12 months a blood test is performed (at the time of, or shortly after the last vaccine) to check eradication of the virus. In the case of a positive test, the baby would be referred to the paediatric team.


Meningitis C “Freshers” (New University Entrants) Programme

Meningitis C (MenC) can cause life threatening disease (meningitis and/ or septicaemia)

The current vaccine schedule for MenC involves 3 vaccines (at ages 3 months,  12/13months and 13/14years).

However, there are a group of young adults who may have only had a single vaccine of MenC at a young age, and this group are at increased risk of MenC disease when entering further education for the 1st time due to close living conditions.

Hence a booster has been recommended for all aged 17-25yrs entering university for the first time and who have not had MenC vaccine since the age of 10.


Shingles Vaccination Programme

In March 2012 the JCVI agreed a roll out programme for shingles vaccination of patients at risk.

This is a single vaccination which gives protection against shingles.

Started in September 2013 with vaccination of those aged 70 and those aged 79.

From April 2017 the shingles vaccine is routinely available to people aged 70. 

In addition, anyone who was eligible for immunisation in the earlier years of the programme but has not yet been vaccinated against shingles remains eligible until their 80th birthday. 

The shingles vaccine is not available on the NHS if you are aged 80 or over.

This is a one off vaccine and does NOT need repeating.


Pertussis (Whooping Cough) Vaccination in Pregnancy Programme

In the first seven months of 2012 before the vaccination programme began, 235 babies under 12 weeks old had whooping cough and 13 babies died from it.

Whooping cough is a serious infection, causing long bouts of coughing and choking, making it hard to catch ones breath. The infection can lead to pneumonia and brain damage. It is particularly important to protect tiny babies from it.

You can protect your baby from getting whooping cough in the first weeks of life by vaccinating yourself in pregnancy. After vaccination, you make antibodies to the bacterium, which cross the placenta and act as protection to your baby after birth.

Following the introduction of whooping cough vaccination in pregnancy, the rate of whooping cough in infants under the age of 12 weeks has fallen dramatically.

Whooping Cough Vaccination in pregnancy should be given -

  • Ideally between 16 and 32 weeks
  • Continues to offer protection if given up to 38 weeks.

Your baby will still need whooping cough (pertussis) vaccine as part of the normal infant immunisation programme starting at 8 weeks. This is because, at that time, the antibodies that were transferred in pregnancy are becoming less active. 

View all

Practice News

Results from 2018-2019 Ash Sur…
Results to March 19
Read more…
Lifestyle Advisers at Ash Surg…
'One You' Lifestyle Advice
Read more…
Paramedic Practitioner to work…
Introduction to new clinical member of staff.
Read more…
Latest CQC Report
Click here to see our latest CQC result and the report
Read more…
Winter Coughs & Colds Info…
Keeping yourself well.....
Read more…
Back to top